Your browser doesn't support javascript.
loading
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Zácková, Daniela; Semerád, Lukás; Faber, Edgar; Klamová, Hana; Stejskal, Lukás; Belohlávková, Petra; Karas, Michal; Cmunt, Eduard; Cerná, Olga; Procházková, Jirina; Cicátková, Petra; Kvetková, Anezka; Hornák, Tomás; Skoumalová, Ivana; Srbová, Dana; Sálek, Cyril; Buffa, David; Voglová, Jaroslava; Jurcek, Tomás; Folta, Adam; Jezísková, Ivana; Zizková, Hana; Machová Poláková, Katerina; Papajík, Tomás; Zák, Pavel; Jindra, Pavel; Svobodník, Adam; Stepánová, Radka; Mayer, Jirí.
Afiliação
  • Zácková D; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic. Zackova.daniela@fnbrno.cz.
  • Semerád L; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Faber E; Dpt. of Hemato-oncology, University Hospital Olomouc and Palacký University, Olomouc, Czech Republic.
  • Klamová H; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Stejskal L; Dpt. of Hemato-oncology, University Hospital Ostrava and Ostrava University, Ostrava, Czech Republic.
  • Belohlávková P; 4th Dpt. of Internal Medicine and Hematology, University Hospital Hradec Králové and Charles University, Hradec Králové, Czech Republic.
  • Karas M; Dpt. of Hemato-oncology, University Hospital Plzen and Charles University, Plzen, Czech Republic.
  • Cmunt E; 1st Dpt. of Internal Medicine - Hematology, General University Hospital, Prague, Czech Republic.
  • Cerná O; Dpt. Of Hematology, University Hospital Královské Vinohrady and Charles University, Prague, Czech Republic.
  • Procházková J; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Cicátková P; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Kvetková A; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Hornák T; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Skoumalová I; Dpt. of Hemato-oncology, University Hospital Olomouc and Palacký University, Olomouc, Czech Republic.
  • Srbová D; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Sálek C; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Buffa D; Dpt. of Hemato-oncology, University Hospital Ostrava and Ostrava University, Ostrava, Czech Republic.
  • Voglová J; 4th Dpt. of Internal Medicine and Hematology, University Hospital Hradec Králové and Charles University, Hradec Králové, Czech Republic.
  • Jurcek T; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Folta A; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Jezísková I; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Zizková H; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Machová Poláková K; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Papajík T; Dpt. of Hemato-oncology, University Hospital Olomouc and Palacký University, Olomouc, Czech Republic.
  • Zák P; 4th Dpt. of Internal Medicine and Hematology, University Hospital Hradec Králové and Charles University, Hradec Králové, Czech Republic.
  • Jindra P; Dpt. of Hemato-oncology, University Hospital Plzen and Charles University, Plzen, Czech Republic.
  • Svobodník A; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Stepánová R; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Mayer J; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Leukemia ; 38(4): 893-897, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38472478
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article